deCODE genetics News
deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
The presentation will be delivered at
About deCODE
deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs and diagnostics for common diseases. deCODE is a global leader in gene discovery — our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. deCODE is also leveraging its expertise in human genetics and integrated drug discovery and development capabilities to offer innovative products and services in personal genome analysis, DNA-based diagnostics, bioinformatics, genotyping, structural biology, drug discovery and clinical development. deCODE is delivering on the promise of the new genetics(SM). Visit us on the web at www.decode.com; on our diagnostics website at www.decodediagnostics.com ; and, for our pioneering personal genome analysis service, at www.decodeme.com .
Contact: deCODE genetics Gisli Arnason +354-570-1825 ir@decode.is
SOURCE deCODE genetics
Search Our News Using Google Search
Can't find what you want? Try using Google:
